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Abstract  22 
The  faecal  egg  count  reduction  test  (FECRT)  is  the  method  of  choice  to  monitor  23 
anthelmintic efficacy against gastro-intestinal nematodes in livestock. Guidelines on how to  24 
conduct  a FECRT are  made  available  by the World  Association  for the Advancement  of  25 
Veterinary Parasitology  (WAAVP).  Since the publication of these  guidelines  in  the  early  26 
1990s,  some  limitations  have  been  noted,  including  (i)  the  ignorance  of  host-parasite  27 
interactions  that  depend  on  animal  and  parasite  species,  (ii)  their  feasibility  under  field  28 
conditions, (iii) appropriateness of study design, and (iv) the low analytic sensitivity of the  29 
recommended faecal egg count (FEC) method. Therefore, the objective of the present study  30 
was to empirically assess the impact of the level of excretion and aggregation of FEC, sample  31 
size and detection limit of the FEC method on the sensitivity and specificity of the FECRT to  32 
detect reduced efficacy (<90% or <95%) and to develop recommendations for surveys on  33 
anthelmintic resistance. A simulation study was performed in which the FECRT (based on the  34 
arithmetic mean of grouped FEC of the same animals before and after drug administration)  35 
was  conducted  under  varying  conditions  of  mean  FEC,  aggregation  of  FEC  (inversely  36 
correlated with k), sample size, detection limit and „true‟ drug efficacies. Classification trees  37 
were built to explore the impact of the above factors on the sensitivity and specificity of  38 
detecting  a  truly  reduced  efficacy.  For  a  reduced-efficacy  threshold  of  90%,  most  39 
combinations resulted in a reliable detection of reduced and normal efficacy. For the reduced- 40 
efficacy threshold of 95% however, unreliable FECRT results were found when sample sizes  41 
<15 were combined with highly aggregated FEC (k = 0.25) and detection limits ≥5 EPG or  42 
when combined with detection limits ≥15 EPG. Overall, an increase in sample size and mean  43 
preDA FEC, and a decrease in detection limit improved the diagnostic accuracy.  FECRT  44 
remained inconclusive under any evaluated condition for drug efficacies ranging from 87.5%  45 
to 92.5% for a reduced-efficacy-threshold of 90% and from 92.5% to 97.5% for a threshold of  46 Page 3 of 19
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95%. The results highlight that (i) the interpretation of this FECRT is affected by a complex  47 
interplay of factors, including the level of excretion and aggregation of FEC  and (ii) the  48 
diagnostic  value  of  FECRT  to  detect  small  reductions  in  efficacy  is  limited.  This  study,  49 
therefore, provides a framework allowing researchers to adapt their study design according to  50 
a  wide  range  of  field  conditions,  while  ensuring  a  good  diagnostic  performance  of  the  51 
FECRT. 52 Page 4 of 19
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1. Introduction  53 
The periodic administration of anthelmintics is currently the most widely used method to  54 
control  gastrointestinal  nematode  infections  in  animals.  Rather  than  aiming  to  achieve  55 
elimination, these control programmes focus on reducing infection intensity and transmission  56 
to  prevent  production  losses  (Shaw  et  al.,  1998;  Charlier  et  al.,  2009).  The  four  major  57 
anthelmintic  families  are  the  benzimidazoles,  imidazothiazoles/tetrahydroxypyrimidines,   58 
macrocyclic lactones and the amino-acetonitrile derivates. The intensive use of anthelmintics  59 
has led to an increasing problem of anthelmintic resistance and the need to monitor and detect  60 
changes in drug efficacy (Wolstenholme et al., 2004; Kaplan, 2004). Now, the faecal egg  61 
count reduction test (FECRT) is the method of choice to monitor anthelmintic efficacy and  62 
guidelines on how to conduct a FECRT were described by the World Association for the  63 
Advancement of Veterinary Parasitology (WAAVP) (Coles et al., 1992). These guidelines  64 
provide recommendations on the experimental set up (randomized control trial), sample size  65 
(≥10 or ≥15 animals per treatment group, each excreting at least 150 eggs per gram of faeces  66 
(EPG)), the faecal egg count (FEC) method (McMaster egg counting method with detection  67 
limit of 10 to 50 EPG, (MAFF, 1986)), statistical analysis (FECRT based on the arithmetic  68 
mean  of  grouped  FEC  after  drug  administration)  and  criteria  defining  reduced  efficacy  69 
(FECRT <90% or FECRT <95% and lower limit of 95% confidence interval <90%), and this  70 
for a variety of animal species, including small ruminants (sheep and goats), cattle, horses and  71 
pigs.  The WAAVP  guidelines  do not  consider the variation in  fecundity  and aggregation  72 
between (e.g. Ascaris suum and Trichuris suis infections in pigs) and within parasite species  73 
(e.g.  the  influence  of  immunity  development  on  egg  shedding).  Moreover,  the  74 
recommendations on the study design and the sample size are stringent, and can be difficult to  75 
meet under field conditions. McKenna (2006) and Dobson et al. (2011) found that sensitivity  76 
was reduced when using the randomized controlled study design advocated in the WAAVP  77 Page 5 of 19
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guidelines;  the latter also  found it to  be a poor  study  design when parasites  were highly  78 
aggregated.  Hence,  FECRT  based  on  the  arithmetic  mean  of  grouped  FEC  of  the  same  79 
animals before and after drug administration (Kochapakdee et al., 1995) is likely to provide  80 
more reliable results. Finally, the high detection limit of the recommended FEC method may  81 
thwart the precision of FECRT results (Levecke et al., 2011a). Alternative FEC methods are  82 
FLOTAC (Cringoli et al., 2010) and FECPAK (www.fecpak.com), allowing for the detection  83 
of 1 and 5 EPG, respectively.   84 
The objective of the present study was to empirically assess the impact of sample size,  85 
detection limit of the FEC method, and level of excretion and aggregation of FEC on the  86 
interpretation  of  the  FECRT  in  the  absence  of  a  control  group.  To  this  end,  data  were  87 
generated using a statistical simulation and subsequently analysed using tree based-models.  88 
From  the  results,  we  provide  recommendations  for  future  study  designs  to  monitor  drug  89 
efficacy against gastrointestinal nematodes of veterinary importance.   90 
  91 
2. Methods  92 
The  study  consisted  of  two  consecutive  methodological  procedures.  First,  data  were  93 
generated using a simulation in which the „true‟ drug efficacy (TDE) was evaluated by the  94 
FECRT under varying conditions of level of excretion and aggregation of FEC across the host  95 
population, sample size and detection limit of the FEC methods. Subsequently, the obtained  96 
data were analyzed using tree-based models, to determine their impact on the interpretation of  97 
FECRT and to assess critical values in terms of specificity to detect normal efficacy and  98 
sensitivity to detect reduced efficacy.   99 
     100 
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  102 
2.1. Data generation  103 
Data were generated by Monte Carlo simulation as previously described by Levecke et al.  104 
(2011b) and are illustrated in Supplemental Figure 1. First, the distribution of parasites within  105 
the  host  population  before  administration  of  drugs  was  defined  by  a  negative  binomial  106 
distribution.  This  distribution  is  determined  by  two  parameters:  the  mean  level  of  egg  107 
excretion  across  animals  (mean  pre-drug  administration  (preDA)  FEC)  and  the  level  of  108 
aggregation of FEC across animals (k). Low values of k indicate that only few animals are  109 
excreting the majority of the eggs, high values indicate that egg counts are more equally  110 
distributed  across  the  host  population.  From  this  pre-defined  distribution,  a  number  of  111 
individual  animals  were  randomly  drawn  representing  the  sample  size.  The  preDA  FEC  112 
observed, however, will be different from the „true‟ preDA FEC due to the variation (i.e.  113 
stochasticity) introduced by sampling eggs associated with the FEC method. This component  114 
of variation was simulated using the Poisson distribution defined by the expected number of  115 
eggs counted (=‟true‟ preDA FEC/detection limit). In order to simulate a TDE, the „true‟  116 
preDA  FECs  of  these  animals  were  multiplied  by  1-TDE.  The  observed  FEC  after  the  117 
administration of the drug (postDA FEC) was generated as described above for the preDA  118 
FEC.  Subsequently,  the  FECRT  was  calculated  as  described  in  the  formula  below  119 
(Kochapakdee et al., 1995), and is based on the arithmetic mean of pre- and postDA FEC of  120 
the same animals. Finally, the entire process was iterated 500 times, to obtain 500 estimates of  121 
FECRT given a pre-defined parasite population, sample size, detection limit and TDE.  122 
FECRT (%)=100% x 
arithmetic mean (preDA FEC) - arithmetic mean (postDA FEC)
arithmetic mean (preDA FEC)
  123 
  124 
The parasite/host population parameter values chosen for mean preDA FEC (50, 100,  125 
150, 200, 250, 300, 350, 400, 450, 500, 600, 700, 800, 900 and 1,000) and k (0.1, 0.25, 0.5,  126 Page 7 of 19
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0.75, 1, 1.5 and 2) were based on previously  conducted studies  in  which  gastrointestinal  127 
nematodes were quantified in goats (Hoste et al., 2002), sheep (Morgan et al., 2005), cattle  128 
(El-Abdellati et al., 2010), horses, pigs and camelids (Laboratory of Parasitology, Faculty of  129 
Veterinary  Medicine,  Ghent  University  (Belgium),  unpublished  data).  The  values  for  the  130 
sample size were 6, 10, 15, 20, 25, 50, 75, 100, 125, 150, 175 and 200, covering a large range  131 
of herd sizes. The values for detection limit represented those of four currently used FEC  132 
methods:  FLOTAC  (detection  limit  =  1  and  2  EPG)  (Cringoli  et  al.,  2010),  FECPAK  133 
(detection limit = 5 and 10 EPG) (www.fecpak.com) and McMaster (detection limit = 10, 15,  134 
25, 33.3 and 50 EPG) (MAFF, 1986). The TDE was set on 50, 60, 70, 80, 82.5, 85, 87.5, 90,  135 
92.5, 95, 97.5 and 99%, resulting in 120,960 combinations (15 (mean preDA FEC) x 7 (k) 12  136 
x (sample size) x 8 (detection limit) x 12 (TDE)) that were each iterated 500 times.  137 
  138 
2.2. Analysis of data using tree-based models  139 
The impact of the various factors on the sensitivity and specificity of the FECRT was  140 
evaluated. Every TDE that was less than 90% or 95% was considered as a truly reduced  141 
efficacy and as truly efficacious if different.   142 
A  combination  of  evaluated  factors  (500  iterations)  was  considered  to  be  “sensitive”  143 
when a FECRT could be calculated (observed mean preDA FEC >0) and a truly reduced  144 
efficacy (TDE <90% or <95%) was correctly detected in at least 95% of the iterations or  145 
“insensitive”  (i.e.  false  negative)  otherwise.  A  combination  of  evaluated  factors  was  146 
considered to be “specific” when a FECRT could be calculated (observed mean preDA FEC  147 
>0)  and  TDE  ≥90  or  ≥95%  was  correctly  detected  in  at  least  95%  of  the  iterations  or  148 
“aspecific” (false positive) otherwise.   149 
Subsequently, tree-based models (classification trees) were built (Speybroek et al., 2004)  150 
to determine critical values for the parasite-host population (mean preDA FEC and k), the  151 Page 8 of 19
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sample size, and the detection limit affecting the interpretation of the FECR. To this end, the  152 
packages „rpart‟ (Speybroeck, 2011) and „randomforest‟ from the statistical software R was  153 
used (version 2.10.0, 2009, The R Foundation for Statistical Computing) with both sensitivity  154 
and specificity as a binary outcome variable and mean preDA FEC, aggregation (k), sample  155 
size, detection limit and TDE as predictor variables.  156 
  157 
3. Results   158 
3.1. Detection of a normal or reduced efficacy for a threshold of 90%  159 
The different combinations of sample size, detection limit, mean preDA FEC and k, and  160 
their respective TDE limits for which the FECRT cannot reliably provide a correct diagnosis  161 
(sensitivity and specificity <85%) are summarized in Figure 1.   162 
For small sample sizes (6 and 10 animals), detection limit was the most important factor:  163 
the reliability of diagnosing reduced and normal efficacy increased when the detection limit  164 
decreased. With a detection limit ≥15 EPG reduced and normal efficacy could only reliably be  165 
detected when the TDE ≤60% and ≥95%, respectively, whereas a detection limit of 1 and 2  166 
EPG allowed to accurately detect reduced and normal efficacy up to a TDE of ≤87.5% and  167 
≥95.0%, respectively.    168 
For moderate (15 and 25 animals) sample sizes, FECRT results were also affected by  169 
mean  preDA  FEC:  FECRT  results  were  less  discriminatory  when  mean  preDA  FEC  170 
decreased. However, the impact of mean preDA FEC on the detection of reduced and normal  171 
efficacy decreased when detection limit decreased. For detection limits ≥15 EPG, the TDE  172 
limits where ≤60% and ≥95% when mean preDA FEC were low (50 and 100 EPG), whereas  173 
detection of normal and reduced efficacy became more reliable when mean preDA FEC were  174 
≥150 EPG (≤82.5% and ≥95.0%). For detection limits of 1 and 2 EPG, the TDE limits to  175 Page 9 of 19
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accurately detect reduced and normal drug efficacy were ≤87.5% and ≥95.0%, regardless of  176 
the mean preDA FEC.  177 
For large sample sizes (≥ 50 animals), the FECRT was able to detect reduced and normal  178 
efficacy when TDE were ≤87.5% and ≥92.5%, except for combinations where detection limits  179 
≥10 EPG were combined with a mean preDA FEC of 50 and 100 EPG, for these combinations  180 
the TDE limits were ≤82.5% and ≥92.5%.  181 
For  the  90%  threshold  aggregation  of  the  FEC  (k)  had  no  effect  on  specificity  or  182 
sensitivity.  183 
<Figure 1 near here>  184 
  185 
3.2. Detection of a normal or reduced efficacy for a threshold of 95%   186 
In analogy with a threshold of 90%, the different combinations of sample size, detection  187 
limit, mean preDA FEC and k, and their respective TDE limits are summarized in Figure 2. In  188 
comparison  with  a  threshold  of  90%,  four  important  differences  can  be  noted.  First,  the  189 
aggregation of the FEC did affect the FECRT results. Moreover, for small sample sizes (6 and  190 
10 animals) combined with highly aggregated FEC (k = 0.1) and detection limits of 5, 10 and  191 
15 EPG or combined with detection limits ≥15 EPG and mean preDA FEC of 50 and 100  192 
EPG did not allow for a reliable detection of a reduced and normal efficacy. Finally, the  193 
variation  in  TDE  limits  across  the  remaining  combinations  was  small.  The  least  194 
discriminatory  FECRT  results  were  observed  for  sample  sizes  (6  and  10  animals)  (TDE  195 
limits: ≤85.0% and ≥97.5%). The most discriminatory combinations (TDE limits: ≤92.5% and  196 
≥97.5%) were found for: (1) sample sizes of 15 and 25 animals combined with detection  197 
limits of 1, 2 5 and 10 EPG and mean preDA FEC ≥250 EPG, (2) sample sizes ≥50 combined  198 
with detection limit of 1, 2 5 and 10 EPG EPG, and (3) sample sizes ≥50 combined with a  199 Page 10 of 19
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detection limit ≥15 EPG and preDA FEC ≥150 EPG. In the remaining combinations the TDE  200 
limits were ≤87.5% and ≥97.5%.  201 
  <Figure 2 near here>  202 
4. Discussion  203 
The present study provides novel insights into three aspects of the FECRT in absence of a  204 
control group. The first important finding is that a correct interpretation of the FECRT is not  205 
always possible. This can be due to factors inherent to the study design, but also to the level  206 
of excretion and aggregation of eggs within the host population. For a threshold of 95%, we  207 
must accept poor diagnostic performance when small sample sizes (6 and 10 animals) are  208 
combined with highly aggregated FEC (k = 0.1) and detection limits of 1, 2, 5, 10 and 15 EPG  209 
or when these sample sizes are combined with high detection limits (≥15 EPG) and low mean  210 
preDA FEC (50 and 100 EPG). As a consequence, previous studies that assessed anthelmintic  211 
efficacy  performed  under  these  conditions  may  have  resulted  in  inconclusive  results  and  212 
should  be  interpreted  with  caution  (e.g.  El-Abdellati  et  al.,  2010).  Secondly,  the  results  213 
highlight  that  their  will  always  be  an  interval  of  TDE  for  which  the  FECRT  remains  214 
inconclusive, even in optimal conditions of sample size, detection limit, mean preDA FEC  215 
and aggregation (cfr. Figure 1 and 2). These intervals range from 87.5% to 92.5% and from  216 
92.5% to 97.5% for a 90% and 95% threshold, respectively. Finally, the results indicate that  217 
recommendations on the sample size can be less stringent in cases where FEC methods that  218 
are more sensitive than McMaster are applied. We, therefore, believe that Figures 1 and 2 can  219 
provide researchers with the flexibility to adapt their study design according to a wide range  220 
of field conditions.  221 
Based  on  a  comparison  of  FECRT  results  with  control  slaughter  data  to  detect  222 
anthelmintic resistance both McKenna (2006) and Dobson et al. (2011) found specificity to be  223 
100%, that is, susceptible nematode isolates were correctly diagnosed as susceptible.  They  224 Page 11 of 19
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found sensitivity to be around 90-95%, that is, most resistant nematode isolates were correctly  225 
diagnosed as resistant. The results of this study were consistent with their findings as the  226 
range of true drug efficacies that provide doubtful results were generally greater below the  227 
threshold than above it (cfr. Figure 1 and 2). In practice other factors that may lead to a false  228 
declaration of reduced efficacy, such as faulty equipment, incorrect dosage, missed animals,  229 
sub-standard product, miss-labeled samples etc. were not considered in this exercise.  In the  230 
laboratory and on farm these are errors that can be difficult to eliminate completely and will  231 
tend  to  reduce  FECRT  specificity.  By  comparison  with  preDA  FEC,  detection  level  and  232 
sample  size  aggregation  of  FEC  (k)  played  a  minor  role  in  FECRT  precision  when  the  233 
threshold was 95% and had no effect on precision when the threshold was 90%. This was  234 
because  the  simulated  study  design  (pre-  and  post-treatment  FEC  of  the  same  animals)  235 
minimizes the negative impact of small k on FECRT precision. The advantage of this design  236 
over FECRT involving separate treated and control groups was demonstrated by Dobson et al.  237 
(2011) for k set at 0.5 and 2.  238 
Anthelmintic  drug  efficacy  in  vivo  is  monitored  by  the  FECRT,  whereas  the  239 
evaluation/registration of efficacy of novel anthelmintic compounds for veterinary application  240 
requires the assessment of reduction in gastrointestinal nematode counts (Vercruysse et al.,  241 
2001; 2002). In analogy with the FECRT, there is a large variation in the number and the  242 
aggregation  of  gastrointestinal  nematodes  across  animals.  Current  guidelines  recommend  243 
counting at least 2% of the gastrointestinal nematode population collected (detection limit =  244 
50 gastrointestinal nematodes), but, as for the FECRT guidelines, the level of understanding  245 
of the effects of factors inherent to study design, parasite and/or host species to support these  246 
guidelines is poor. Therefore, a similar approach as in this study might also be used to deduct  247 
implications  for study designs  assessing drug efficacy based on  gastrointestinal  nematode  248 
counts.    249 Page 12 of 19
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Although  this  simulation  provides  novel  insights  in  the  FECRT,  we  should  also  250 
underscore the limitations of the present study. First, this analysis only improves the selection  251 
of a study design. For the reliability of a conclusion towards presence of reduced efficacy on  252 
an individual case, 95% confidence intervals are still to be calculated (Coles et al., 1992,  253 
Dobson  et  al.,  2011,  Vidyashankar  et  al.,  2012).  Second,  we  did  not  consider  additional  254 
variation caused by differences in properties of the FEC method beyond the detection limit  255 
(Cringoli et al., 2004; Pereclienė et al., 2007;  Cringoli et al., 2010). Extrapolation of the  256 
performance  of  FECR  across  different  FEC  methods  should  be  done  with  care  as  recent  257 
studies show that FEC methods with the same detection limit, but different methodologies, do  258 
not guarantee an equal level of performance of FECR (Levecke et al., under review). Finally,  259 
this simulation is restricted to parasite populations defined by a mean baseline FEC between  260 
50 and 1,000 EPG, k between 0.01 and 2, and sample sizes between 6 and 200, and did only  261 
explore a limited number of values between these intervals.  262 
In conclusion, this study assessed the impact of various factors on the interpretation of  263 
probably the most reliable FECRT design. The results highlight that the interpretation of the  264 
FECRT is affected by a complex interplay of various factors, including the mean and level of  265 
aggregation of FEC. This study provides an empirical-based framework allowing researchers  266 
to adapt their study design according to a wide range of field conditions, while ensuring a  267 
good diagnostic performance of the FECRT.  268 
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Figure captions  352 
Figure 1. The detection of reduced (true drug efficacy <90%) and normal drug efficacy (true  353 
drug  efficacy  ≥90%).  The  white  zone  indicates  which  drug  efficacies  can  be  accurately  354 
determined by FECRT as having reduced efficacy, whereas the black zone indicates which  355 
drug efficacies can be accurately determined as having a normal efficacy. The grey zone  356 
indicates drug efficacies that cannot be accurately determined as having either reduced or  357 
normal efficacy.  358 
   359 
Figure 2. The detection of reduced (true drug efficacy <95%) and normal drug efficacy (true  360 
drug  efficacy  ≥95%).  The  white  zone  indicates  which  drug  efficacies  can  be  accurately  361 
determined by FECRT as having reduced efficacy, whereas the black zone indicates which  362 
drug efficacies can be accurately determined as having a normal efficacy. The grey zone  363 
indicates drug efficacies that cannot be accurately determined as having either reduced or  364 
normal efficacy.  365 
  366 
Supplemental Figure 1. Schematic presentation of the data generation based on Monte Carlo  367 
simulation.  368 Page 18 of 19
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